Doctors and medical specialists in the Netherlands more often prescribe more expensive drugs if the drugs are from the pharmaceutical company that pays their sponsorship money, according to a study done by the Volkskrant and health insurer VGZ.
Dutch pharmaceuticals and oncologists are teaming up in a new experiment to test experimental cancer drugs on patients quickly and safely. Pharmaceuticals will make their cancer drugs available to oncologists, who in exchange will let them know how patients react to the medicines
The number of medicines temporarily unavailable in the Netherlands increased sharply over the past years. In five years the shortages quadrupled, according to pharmacists organization KNMP
Minister Edith Schippers of Public Health and her Belgian counterpart Maggie de Block are teaming up in negotiations with pharmaceutical companies on the prices of expensive drugs. This agreement was made on Monday during a European Council of Health Ministers in Riga.